Delivery Order SPE2DB20D3103-SPE2DB22FM3D0

Award Date 1/14/22
Potential Completion Date 1/18/22
Potential Value $3.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,172.90 firm-fixed-price delivery order is for the supply of ZORTRESS 1 MG TABLET UD 60S, a pharmaceutical product. The contract has an ultimate completion date of May 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award, with ID SPE2DB22D3009|SPE2DB25FAT21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zortress 1 mg tablet units, valued at $18,573.23. It is a Firm Fixed Price Delivery Order contract with a completion date of March 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,123.89 firm fixed-price delivery order is for the pharmaceutical product ZORTRESS 0.5 MG TABLET UD 60S, with a period of performance through July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $1,005.00, is for the delivery of the pharmaceutical product ZORTRESS 0.5 MG TABLET UD 60S. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency, and has a firm fixed price and an ultimate completion date of June 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,592.83 firm fixed-price delivery order is for the supply of Zortress 0.25 mg tablet medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, with the ID SPE2DB22D3009|SPE2DB25FAN26, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Zortress 0.5 mg tablets, a pharmaceutical product, with a ceiling value of $15,074.60 and a completion date of January 10, 2025. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare...
The Defense Logistics Agency awarded a delivery order valued at $356.65 to Amerisourcebergen Drug Corporation for the supply of 4562259712 Zortress 0.25 MG tablets in unit dose packaging of 60 tablets. The firm fixed price order calls for delivery to a facility in Conshohocken, Pennsylvania by September 8, 2023 to support DLA programs. Amerisourcebergen will perform as the prime contractor, drawing upon its expertise in pharmaceutical distribution for the U.S. Department of Defense. No...
The Defense Logistics Agency awarded a $713 delivery order to Amerisourcebergen Drug Corporation for 4561391855 Zortress 0.25 MG tablets to be delivered within a three-day period ending July 3, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency procures pharmaceuticals and other medical commodities in support of the U.S. Department of Defense healthcare system and readiness...
This federal contract award is for the delivery of Sirolimus 1 mg tablets in quantities of 100 to the Defense Logistics Agency (DLA). The contract, valued at $3,012.92, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a firm fixed-price delivery order with a completion date of January 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of Everolimus 1 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $13,406.09 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 28, 2024. Amerisourcebergen is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, with a focus on supporting the...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FM3D0
    Delivery Order

This federal contract award is for the delivery of Zortress 0.5 mg tablets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 14, 2022, with a ceiling value of $3,506.60 and an ultimate completion date of January 18, 2022. The contract is a delivery order with a firm fixed price pricing type.

Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, that serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with a set-aside requirement, indicating open competition.

Generated 2/27/25, 10:56 AM